Typhoid Fever - Pipeline Review, H1 2017

Publisher Name :
Date: 28-Feb-2017
No. of pages: 41
Inquire Before Buying

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Typhoid Fever - Pipeline Review, H1 2017, provides an overview of the Typhoid Fever (Infectious Disease) pipeline landscape.

Typhoid fever is an infection that causes diarrhea and a rash. It is most commonly due to a type of bacterium called Salmonella typhi (S. typhi). Symptoms include abdominal tenderness, agitation, chills, delirium, hallucinations, severe fatigue and weakness. Treatment includes antibiotics and supportive therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Typhoid Fever - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Typhoid Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 1, 1, 4, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Typhoid Fever (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note*: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Typhoid Fever (Infectious Disease).

  • The pipeline guide reviews pipeline therapeutics for Typhoid Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

  • The pipeline guide reviews key companies involved in Typhoid Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.

  • The pipeline guide evaluates Typhoid Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

  • The pipeline guide reviews latest news related to pipeline therapeutics for Typhoid Fever (Infectious Disease)

Reasons to buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

  • Find and recognize significant and varied types of therapeutics under development for Typhoid Fever (Infectious Disease).

  • Classify potential new clients or partners in the target demographic.

  • Develop tactical initiatives by understanding the focus areas of leading companies.

  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

  • Formulate corrective measures for pipeline projects by understanding Typhoid Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Typhoid Fever - Pipeline Review, H1 2017

Table of Contents

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Typhoid Fever - Overview
Typhoid Fever - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Typhoid Fever - Therapeutics Assessment
Assessment by Target
Assessment by Route of Administration
Assessment by Molecule Type
Typhoid Fever - Companies Involved in Therapeutics Development
GlaxoSmithKline Plc
Indian Immunologicals Ltd
Nanotherapeutics Inc
Prokarium Ltd
Protein Potential LLC
Sanofi Pasteur SA
Shantha Biotechnics Ltd
SK Chemicals Co Ltd
Zydus Cadila Healthcare Ltd
Typhoid Fever - Drug Profiles
(paratyphoid (bivalent) + typhoid) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(paratyphoid + typhoid) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(shigella + typhoid) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(Streptococcal pneumonia + typhoid) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Typhella - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
typhoid Vi polysaccharide [strain S typhi Ty2] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ViCRM-197 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Typhoid Fever - Dormant Projects
Typhoid Fever - Discontinued Products
Typhoid Fever - Product Development Milestones
Featured News & Press Releases
Oct 05, 2012: Sanofi Pasteur Voluntarily Recalls Few Batches Of Typhoid Fever Vaccine
Jun 23, 2011: Sanofi Pasteur's Typhim Vi Receives Prequalification From World Health Organization
Jun 05, 2008: Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate
Jan 08, 2008: Emergent BioSolutions Announces Final Phase II Clinical Study Results for Typhoid Vaccine
Nov 21, 2005: Emergent Biosolutions Starts Clinical Study Of Single-Dose Oral Typhoid Vaccine
Aug 30, 2005: Emergent Biosolutions' Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study
Nov 29, 1994: Food And Drug Administration Grants License For A New Typhoid Fever Vaccine
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables

Number of Products under Development for Typhoid Fever, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Typhoid Fever - Pipeline by GlaxoSmithKline Plc, H1 2017
Typhoid Fever - Pipeline by Indian Immunologicals Ltd, H1 2017
Typhoid Fever - Pipeline by Nanotherapeutics Inc, H1 2017
Typhoid Fever - Pipeline by Prokarium Ltd, H1 2017
Typhoid Fever - Pipeline by Protein Potential LLC, H1 2017
Typhoid Fever - Pipeline by Sanofi Pasteur SA, H1 2017
Typhoid Fever - Pipeline by Shantha Biotechnics Ltd, H1 2017
Typhoid Fever - Pipeline by SK Chemicals Co Ltd, H1 2017
Typhoid Fever - Pipeline by Zydus Cadila Healthcare Ltd, H1 2017
Typhoid Fever - Dormant Projects, H1 2017
Typhoid Fever - Discontinued Products, H1 2017

List of Figures

Number of Products under Development for Typhoid Fever, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Targets, H1 2017
Number of Products by Stage and Targets, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017
  • Global Cephalosporin Sales Market Report 2017
    Published: 12-Dec-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Cephalosporin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Cephalosporin for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan -......
  • Global Polymixin Market Professional Survey Report 2017
    Published: 07-Dec-2017        Price: US 3500 Onwards        Pages: 106
    This report studies Polymixin in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Shengxue Dacheng - Apeloa - Livzon Group - LKPC - Xellia - B......
  • Global Cefprozil Market Professional Survey Report 2017
    Published: 06-Dec-2017        Price: US 3500 Onwards        Pages: 114
    This report studies Cefprozil in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Orchid - Taj?Pharma - Dhanuka - Lupin - Alkem - Corden Pharm......
  • Global Polymixin (B and E) Market Research Report 2017
    Published: 04-Dec-2017        Price: US 2900 Onwards        Pages: 114
    In this report, the global Polymixin (B and E) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Polymixin (B and E) in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • United States Ganciclovir Market Report 2017
    Published: 29-Nov-2017        Price: US 3800 Onwards        Pages: 103
    In this report, the United States Ganciclovir market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Ganc......
  • Global Cephalosporin Market Research Report 2017
    Published: 27-Nov-2017        Price: US 2900 Onwards        Pages: 104
    In this report, the global Cephalosporin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cephalosporin in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Ganciclovir Sales Market Report 2017
    Published: 24-Nov-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the global Ganciclovir market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Ganciclovir for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan - Southeast Asi......
  • United States Tigecycline Market Report 2017
    Published: 22-Nov-2017        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Tigecycline market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Tige......
  • Global Tigecycline Sales Market Report 2017
    Published: 17-Nov-2017        Price: US 4000 Onwards        Pages: 118
    In this report, the global Tigecycline market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Tigecycline for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - South......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs